Citadel Advisors »

Cara Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $87k 116k 0.74
2023-09-30 $138k 82k 1.68
2023-06-30 $903k 319k 2.83
2023-03-31 $2.8M 561k 4.91
2022-12-31 $1.8M 166k 10.74
2022-06-30 $2.8M 311k 9.13
2022-03-31 $3.5M 289k 12.15
2021-12-31 $2.1M 172k 12.24
2021-09-30 $3.6M 234k 15.45
2021-06-30 $2.3M 162k 14.26
2021-03-31 $11M 527k 21.71
2020-12-31 $5.7M 375k 15.13
2020-09-30 $2.8M 216k 12.73
2020-06-30 $0 114k 0.00
2020-03-31 $1.2M 91k 13.21
2019-12-31 $2.6M 162k 16.14
2019-09-30 $10M 565k 18.28
2019-06-30 $10M 478k 21.50
2019-03-31 $7.8M 400k 19.62
2018-12-31 $2.1M 163k 13.00
2018-09-30 $4.0M 167k 23.94
2018-06-30 $3.3M 170k 19.15
2018-03-31 $1.3M 108k 12.39
2017-12-31 $1.5M 120k 12.24
2017-09-30 $2.0M 148k 13.69
2017-06-30 $2.6M 169k 15.39
2017-03-31 $3.5M 189k 18.39
2016-12-31 $358k 39k 9.27
2016-09-30 $563k 68k 8.35
2015-12-31 $1.6M 92k 16.86
2015-09-30 $867k 61k 14.29